Dr Karl Smith-Byrne
Contact information
Research groups
- Analysing the blood proteome of three poorly understood cancers in Europe
- Assessing structural variation and the non-coding genome in prostate cancer
- Assessing the impact of somatic mosaicism on the blood proteome and cancer risk
- Assessing the role of structural variation on the blood proteome and cancer risk
- Assessing the role of structural variation on the blood proteome and cancer risk
- Leveraging genetic admixture and relatedness to advance rare variant discovery in the Mexico City Prospective Study
Karl Smith-Byrne
BSc, MPhil, DPhil
Senior Molecular Epidemiologist
Karl works as a senior molecular epidemiologist at the Cancer Epidemiology Unit (CEU) at the University of Oxford.
He co-leads the metabolomics and proteomics research programe into the aetiology of prostate cancer using an integrative multi-omits approach and research risk prediction for various cancer outcomes within the Million Women Study.
Karl is also a research fellow at Green Templeton College.
He completed my post-doctoral work at the Genomic Epidemiology Branch of the International Agency for Research on Cancer in Lyon, France. There, he focussed on implementing multi-omic methods to better understand factors contributing the aetiology, early detection, and prognosis of various cancers, in particular, lung and renal neoplasms.
Karl completed his DPhil in Population Health at the University of Oxford, focussing on the molecular epidemiology of prostate cancer, with a focus on genetics and proteomics.
Before that, he acquired a MPhil in Biological Anthropology with a focus on human evolutionary perspectives on cancer genomics at the University of Cambridge.
Karl also read for a BSc in Psychology with a focus on cognitive neuroscience and behavioural ecology at the University of Dundee.